Поставка лекарственного препарата (Дурвалумаб)

This tender, originating from the Chelyabinsk Oblast, Russia, and sourced via gosplan_ru, is for the supply of a specific pharmaceutical product: Durvalumab. The contracting authority requires this medication, which is a type of immunotherapy used in cancer treatment. Suppliers must be authorized pharmaceutical distributors or manufacturers capable of providing genuine Durvalumab that meets all regulatory and quality requirements for medicinal products in Russia. Key tender requirements will include proof of authorization to supply pharmaceuticals, adherence to Good Distribution Practices (GDP), and provision of the drug in its original, sealed packaging with appropriate labeling. The tender will likely specify the required dosage form, strength, and quantity. Bidders must provide documentation such as marketing authorization, certificates of analysis, and expiry date information.

Proposals should detail the origin of the drug, delivery terms, and payment conditions. Compliance with all Russian pharmaceutical regulations is paramount. The evaluation will focus on the supplier's legal standing, product authenticity, supply chain integrity, and price.